Methadone withdrawal when starting an antiretroviral regimen including nevirapine

被引:44
作者
Heelon, MW
Meade, LB
机构
[1] Baystate Med Ctr, Dept Pharm, Springfield, MA 01199 USA
[2] Baystate Med Ctr, Dept Med, Springfield, MA 01199 USA
[3] Tufts Med Sch, Springfield, MA USA
来源
PHARMACOTHERAPY | 1999年 / 19卷 / 04期
关键词
D O I
10.1592/phco.19.6.471.31046
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Antiretrovirals from three drug classes, nucleoside analogs, nonnucleoside analogs, and protease inhibitors, can be combined to achieve viral suppression. The nonnucleoside analog nevirapine is an inducer of cytochrome P450 3A4 liver metabolism and has interactions with protease inhibitors and oral contraceptives. Methadone has two roles in human immunodeficiency viral infection. pain management and treatment of opioid abuse. A drug-drug interaction may result in decreased methadone blood levels when administered with nevirapine. A patient experienced methadone withdrawal symptoms when combining these agents.
引用
收藏
页码:471 / 472
页数:2
相关论文
共 6 条
  • [1] Protease inhibitors in patients with HIV disease - Clinically important pharmacokinetic considerations
    Barry, M
    Gibbons, S
    Back, D
    Mulcahy, F
    [J]. CLINICAL PHARMACOKINETICS, 1997, 32 (03) : 194 - 209
  • [2] Hardman J.G., 1996, PHARM BASIS THERAPEU
  • [3] Involvement of cytochrome P450 3A4 enzyme in the N-demethylation of methadone in human liver microsomes
    Iribarne, C
    Berthou, F
    Baird, S
    Dreano, Y
    Picart, D
    Bail, JP
    Beaune, P
    Menez, JF
    [J]. CHEMICAL RESEARCH IN TOXICOLOGY, 1996, 9 (02) : 365 - 373
  • [4] *MICR INC, DRUGD SYST, V99
  • [5] Cytochrome P4503A (CYP3A) metabolism: Prediction of in vivo activity in humans
    Wilkinson, GR
    [J]. JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1996, 24 (05): : 475 - 490
  • [6] 1998, AANN INTERN MED, V128, P1079